热门资讯> 正文
Praxis精密药品宣布拟议公开募股
2025-10-17 04:05
- Praxis Precision Medicines (NASDAQ:PRAX) said on Thursday it plans to offer shares of its common stock and prefunded warrants in a public offering, with all securities to be sold by the company.
- The size and pricing of the offering were not disclosed.
- The company granted underwriters a 30-day option to buy up to 15% additional shares.
- PRAX -2.92% after hours to $157.78.
- Source: Press Release
More on Praxis Precision Medicines
- Praxis: Positive 8-Week Radiant Study Data Leads To Other Expected Catalysts
- Praxis surges after late-stage trial success for movement disorder therapy
- Biggest stock movers Thursday: PRAX, HPE, GRAL, FOSL, VERI, and more
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。